← Eichor
Condition: Zoledronic Acid Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Zoledronic Acid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07471516Step-down Therapy After Long-term Osteoporosis Treatment
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT07281586Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Phase 2 · 22 location(s) · Australian and New Zealand Intensive Care Research Centre · NCT04608630Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
Phase 2 · 1 location(s) · AUVA Traumazentrum Vienna Site UKH Meidling · NCT05677152Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07375290Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
Phase 4 · 1 location(s) · University of Aarhus · NCT06859580Continuous Passive Motion Versus Heterotopic Ossification
NA · 1 location(s) · University of Ioannina · NCT05906056Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05595603Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/
Phase 1 · 1 location(s) · Emory University · NCT05400603Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumor
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT02508038Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Ind
Phase 4 · 3 location(s) · Hadassah Medical Organization · NCT06762730Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT06625190StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis
Phase 4 · 17 location(s) · University Hospital, Toulouse · NCT06767150Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
Phase 1/Phase 2 · 1 location(s) · Qilu Hospital of Shandong University · NCT06759064A Study to Improve the Collaboration Between Primary and Secondary Health Care on the Treatment of Osteoporosis After a
NA · 1 location(s) · University Hospital, Akershus · NCT05904353
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.